Birgit C Schultes

NTLA

Birgit C Schultes serves as EVP, Chief Scientific Officer at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$78.9K

Net Position

Net Seller

$78.9K

Companies Traded

NTLA

Active Period

Oct 2025 – Jan 2026

2 total trades

Most Recent

Sell NTLA

Jan 5, 2026 · $78.4K

Birgit C Schultes's Insider Trading at Intellia Therapeutics, Inc. (NTLA)

Buys

0 · $0.00

Sells

2 · $78.9K

Total Shares Bought

Total Shares Sold

8,539

NTLA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 5, 2026↗	Sell	8,508	$9.21	$78.4K	0
Oct 1, 2025↗	Sell	31	$17.38	$538.78	0

Related Insiders

Eliana Clark

officer: EVP, Chief Technical Officer

NTLASell · Mar 3, 2026

BASTA JAMES

officer: EVP, General Counsel

NTLASell · Mar 3, 2026

LEONARD JOHN M

President and CEO

NTLASell · Jan 5, 2026

Edward J Dulac III

EVP, Chief Financial Officer

NTLASell · Jan 5, 2026

David Lebwohl

EVP, Chief Medical Officer

NTLASell · Jan 5, 2026

BASTA JAMES

EVP, General Counsel

NTLASell · Jan 5, 2026

Eliana Clark

EVP, Chief Technical Officer

NTLASell · Jan 5, 2026

Fred E Cohen

Director

NTLABuy · Jan 5, 2026

Explore More Insider Trading Data

NTLA Insider Trading Activity

View all insider trades at Intellia Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity